This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
附属机构
This person is not affiliated with any business or Blue Board record at ProZ.com.
翻译文本 - Chinese汉语 The overall treatment time (OTT) is one of the crucial factors in rate of locoregional control in tumors. Reducing the OTT can elevate the rate of locoregional control in tumors[2-6]. Many tumors have a tendency of reproliferation, and tumors will continue to grow regardless of whether possessing reproliferation during the period of treatment. According, it is unreasonable [7] to create any extension unless the treatment period needs to be elevated to inhibit the response of normal tissues to a certain extent. Since the beginning of the 1970s of twentieth century, it was discovered that the accelerated reproliferation in stem cell of surviving tumors is potentially the predominant incentive [8] resulting in the failure of conventional fractionated radiotherapy in diversified types of animal implant tumors and some human tumors, especially in craniopharyngeal, upper respiratory tract carcinoma as well as upper digestive tract squamous cell carcinoma (SCC). It have been confirmed in clinical studies that the accelerated reproliferation of cancer cells in the craniopharyngeal tumors is the leading cause in inducing failure of treatment [9.10]. The accelerated reproliferation is associated with the potential doubling time (Tpot) of tumors. Tpot of craniopharyngeal carcinoma is 4.7 to 5.5 days and Tpot of esopharyngeal tract carcinoma is 6.8 days, reported by Fowler et al [11]. Elongated overall treatment time of conventional fractionated radiotherapy is possibly unfavorable for treating tumors, being rapid reproliferation. Accordingly, it is recommended [12] that accelerated hyperfractionated radiotherapy could be utilized on Tpot of tumors smaller than 3d and hyperfractionated radiotherapy operated on Tpot of tumors between 3 to 8d as well as conventionally fractionated radiotherapy applied on Tpot of tumor larger than 8d. Under the strong promotion of radiobiology, researchers from various countries started to be devoted themselves to investigating some novel fractionated radiotherapy to overcome the accelerated reproliferation of tumor cells and elevate the efficacy of radiotherapy in the late 1970s and early 1980s, and received some inspiring advancement in the interventions of craniopharyngeal carcinoma, lung cancer, esopharyngeal tract carcinoma, some malignant tumors and so on. It is assumed that the accelerated proliferation of tumors in radiotherapy could be overcome via accelearated hyperfractionated radiotherapy to intensify its efficacy, specifically in the late stage of accelerated radiotherapy in esopharyngeal carcinoma. Some researchers [13-15] in China chose late phase of accelerated radiotherapy that had already significantly improved the rate of locoregional control and survival on esopharyngeal carcinoma patients.
Get help on technical issues / improve my technical skills
Learn more about additional services I can provide my clients
Help or teach others with what I have learned over the years
Transition from freelancer to agency owner
Buy or learn new work-related software
Improve my productivity
档案
Dear Mr. or Ms.,
I am currently working as a medical editor and freelance
translator. Concurrently, I provide my translation and proofreading service for several translation companies, such as Lionbridge (US), SDL (UK), Language Connect (UK), Amitt (Japan), Express-Preklady (Czech), Boffin (Canada & China), 24 Translate (Germany), Language Wire (Denmark & Germany), Language Scientific (US), Babbletype(US- Transcription)...etc. I am familiar with CAT tools like memoQ, SDL trados studio and Xliff editor.
I was noted for achieving the following:
- Proofreading documents of banking and finance
- - Proofreading scientific papers for publishing
(academic English)
-
- - Translating medical textbooks associated with
clinical medicine (English > Traditional Chinese)
- - Organizing medical references via Endnote
software (academic English)
- - Editing the content for patent applications
(Simplified Chinese > English)
- - Translating medical publications (Traditional Chinese > English)
- - Translating pharmaceutical documents (English > Traditional Chinese)
- - Reviewing content of completed transcribed material for QA (Chinese > English)
- - Reviewing content of medical instruments for QA (English to Traditional Chinese)
- - Performing DTP tasks
-
- Conducting Cognitive Debriefing and IMPs labelling (Clinical Trial, Medicine and Pharmaceutics) (English , Chinese)
- Transcription and subtitling of lectures and videos (English <> Chinese)
Furthermore, I have strong academic background to elevate my
work in clinical medicine and pharmaceutical science. Chemistry is one of my professions as well.
I strongly believe that the professional experience above
would make me a valuable contribution to your company. If there is any further
information I need to provide, please do not hesitate to contact me.
Sincerely yours,
Yihsuan Huang
关键词： Chinese, medical, science, medical writing, medical editing, proofreading, patents, medical devices, law, contract. See more.Chinese, medical, science, medical writing, medical editing, proofreading, patents, medical devices, law, contract, IT, Life Science. See less.
